SUMMARY The clinical and haematological features of an unusual case of congenital dyserythropoietic anaemia are described. There was a pronounced haemolytic component to the anaemia, with a mean cell life of five days, and a remarkable response to splenectomy. Measurement of the incorporation of 15N glycine into the haem of circulating red cells and into bilirubin showed that haem turnover due to ineffective erythropoiesis was increased 45 times compared with a control group (11 63 mg/kg/day, NR = 0-26 ± 0 10) and represented 51 % of total erythroid haem turnover.
defined three types of congenital dyserythropoietic anaemia: type 1, megaloblastic erythropoiesis with internuclear chromatin bridges (Wendt and Heimpel, 1967; Heimpel et al., 1971) ; type II, hereditary erythroblastic multinuclearity with a positive acidified serum test (HEMPAS) (Crookston, et al., 1969; Verwilghen et al., 1973) ; and type III, erythroblastic multinuclearity and gigantoblasts (Wolff and Von Hofe, 1951; Bergstrom and Jacobsson, 1962; Goudsmit et al., 1972) . Other congenital dyserythropoietic syndromes have been described by Valentine et al. (1973) and Weatherall et al. (1973) .
The present report describes the clinical and haematological features of a patient with severe congenital dyserythropoietic anaemia (CDA) which does not fall into any of the above categories, and in whom there was a remarkable response to splenectomy. In order to quantitate the degree of ineffective erythropoiesis the incorporation of 15N glycine into the haem of circulating red cells and into bile pigment was measured.
Case report NE, the youngest of four children, was born after a Requests for reprints: Dr Received for publication 21 June 1976 normal pregnancy and delivery. Anaemia and hepatosplenomegaly were first noted at 8 weeks. Both liver and spleen were palpable 3 cm below the costal margin. There was no lymphadenopathy and he was not clinically jaundiced. There was no relevant family history. Initial investigations were as follows: Hb 3 9 g/dl, MCV 76 fl, total WBC 18,900/,ul, neutrophils 11,900/,ul, lymphocytes 7,300/ pl, monocytes 200/,ul, eosinophils 400/pl, occasional myelocytes and metamyelocytes, nucleated red cells 180/100 WBC, reticulocytes 7 0%, and platelets 160,000/,ul. The peripheral blood ( Fig. 1) showed marked anisocytosis and poikilocytosis, spherocytes, schistocytes, polychromasia, Howell-Jolly bodies, and basophil stippling. The marrow (Fig. 2) was hypercellular with marked erythroid hyperplasia, normoblastic erythropoiesis, and gross dyshaemopoiesis. A few binucleate erythroblasts were present at all stages of development but were not a prominent feature, and cells containing more than two nuclei were rare. There were also numerous smear cells and reticulum cells, some showing erythrophagocytosis. Iron stores were normal and there were no ring sideroblasts. The following further investigations were carried out, mainly during the first 6 months of life. The estimated mean cell life of the patient's own cells, using 51Cr labelling and the elution corrections of Garby and Mollison (1971) in this laboratory: IgG 3-0-13'6 g/l, IgA 0-3-1V3 g/l, IgM 0-3-2-3 g/l). Urea and electrolytes, urinary amino acids, chest x-ray, skeletal survey, and intravenous pyelogram were all normal. Chromosomal analysis of blood/marrow cells was not performed.
The patient was transfused soon after admission and subsequently at approximately monthly intervals. He was given desferrioxamine with each transfusion and folic acid supplements. A one-month course of prednisone, 2 mg/kg/day, had no effect on the anaemia or reticulocyte count. Soon after the first transfusion the nucleated red cells fell to between 0 and 5/100 WBC and remained at low levels. The white count fell to normal and the myelocytes and metamyelocytes disappeared from the peripheral blood. The reticulocyte count varied between 0 and 10% but was usually normal (Fig. 3) , often being less than 1 %. In May 1973, when the patient was aged 24, elective splenectomy was performed. The spleen weighed 333 g and histology showed congestion only. Soon after splenectomy the haemoglobin rose to 13-5 g/dl and has subsequently remained between 12 and 13-5 g/dl. The reticulocyte count also rose to levels between 13% and 20% and the mean cell life of the patient's own cells rose to 21 days. Immunoglobulin levels have remained low: IgG 3-3 g/l, IgA 0-9 g/l, IgM 0 3 g/l at age 3 years and 6 months, and IgG 4 5 g/l, IgA 1.0 g/l, IgM 0 3 g/l at age 4 years 11 months (95% NR 1-7 yr in this laboratory: IgG 6-8-11-3, IgA 0-6-1P4, IgM 0-2-1-3). Following splenectomy the patient has been maintained on prophylactic oral penicillin and folic acid supplements and has been quite well apart from one episode of tonsillitis. The liver remains enlarged 4 cm below the costal margin, but growth and development have been otherwise normal and no further transfusion has been required. The haematological parameters before and after splenectomy are shown in Fig. 3 and the post-splenectomy blood film in Figure 4 .
15N GLYCINE STUDY
This was carried out six months after splenectomy when a steady state had been achieved. Informed consent was given by the parents and the study was approved by the Hospital Ethical Committee. The experimental design and methods were as previously described (Samson et al., 1976b) The % 15N glycine lost from peripheral blood haem daily between day 7 and day 17 was derived from the graph (Fig. 5 ). This would give rise to an equal % 15N glycine incorporation into bilirubin on that day which was therefore subtracted from the total % 15N glycine incorporation into bilirubin to give the % 15N glycine incorporated into early labelled bilirubin (Table) . Assuming that all labelled bilirubin produced after day 17 is derived from destruction of circulating red cells (see 1976b), assuming that BRHEp, bilirubin production from hepatic haem turnover, was 0-76 mg/kg/day (mean normal value) (Berk et al., 1976) . Haem turnover rates were calculated by converting bilirubin production rates to molar units.
Results
These are summarised in Fig. 5 The excellent response to splenectomy in the present case is undoubtedly related to the severity of the haemolysis, which is an unusual feature of CDA. In the majority of reported cases there was only a moderate reduction in red cell survival (Crookston et al., 1969; Verwilghen et al., 1973) . However, in one case described by Verwilghen et al. (1973) , the Ti 51Cr was 7-25 days and splenectomy (Scharer et al., 1965; Verwilghen et al., 1969; Bright et al., 1972) In the present case total erythroid haem turnover (BRn3 + BRRBc) was increased six times compared with a control group. Haem turnover due to effective red cell production and destruction (BRRBc) was increased three times, consistent with the reduction in mean cell life, but there was a disproportionate increase in haem turnover due to ineffective erythropoiesis (BRIE). BRIE was increased 45 times compared to the control group, a greater increase than that seen in a variety of haematological disorders including homozygous ,B-thalassaemia (Samson et al., 1976c) and pernicious anaemia (Samson et al., 1976a) and accounted for 51 % of total erythroid haem turnover. 
